AU8167498A - Method for inducing a systemic immune response to a hepatitis or hiv antigen - Google Patents

Method for inducing a systemic immune response to a hepatitis or hiv antigen

Info

Publication number: AU8167498A
Authority: AU; Australia
Prior art keywords: hepatitis; inducing; immune response; hiv antigen; systemic immune
Prior art date: 1997-06-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU81674/98A

Inventor

Darryl M. See

Jackie R. See

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

BIOSPHERE TECHNOLOGIES Inc

Original Assignee

Bio Sphere Technology Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-26

Filing date

1998-06-25

Publication date

1999-01-19

1997-10-10 Priority claimed from US08/948,568 external-priority patent/US6207185B1/en

1998-01-14 Priority claimed from US09/007,297 external-priority patent/US6117449A/en

1998-06-25 Application filed by Bio Sphere Technology Inc filed Critical Bio Sphere Technology Inc

1999-01-19 Publication of AU8167498A publication Critical patent/AU8167498A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Virology (AREA)
Mycology (AREA)
Immunology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)

AU81674/98A 1997-06-26 1998-06-25 Method for inducing a systemic immune response to a hepatitis or hiv antigen Abandoned AU8167498A (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US88296897A	1997-06-26	1997-06-26
US08882968		1997-06-26
US08948568		1997-10-10
US08/948,568 US6207185B1 (en)	1996-03-22	1997-10-10	Method for inducing a systemic immune response to an HIV antigen
US09007297		1998-01-14
US09/007,297 US6117449A (en)	1996-03-22	1998-01-14	Method for inducing a systemic immune response to a hepatitis antigen
PCT/US1998/013194 WO1999000142A1 (en)	1997-06-26	1998-06-25	Method for inducing a systemic immune response to a hepatitis or hiv antigen

Publications (1)

Publication Number	Publication Date
AU8167498A true AU8167498A (en)	1999-01-19

Family

ID=27358330

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU81674/98A Abandoned AU8167498A (en)	1997-06-26	1998-06-25	Method for inducing a systemic immune response to a hepatitis or hiv antigen

Country Status (2)

Country	Link
AU (1)	AU8167498A (en)
WO (1)	WO1999000142A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2850872A1 (en) *	2003-02-12	2004-08-13	Ethypharm Sa	Composition containing an antigen of human immune deficiency virus, for use as a vaccine, comprises multilamellar vesicles with an internal liquid crystal structure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4997926A (en) *	1987-11-18	1991-03-05	Scripps Clinic And Research Foundation	Deaminase-stable anti-retroviral 2-halo-2',3'-dideoxy
US5709879A (en) *	1990-06-29	1998-01-20	Chiron Corporation	Vaccine compositions containing liposomes

1998
- 1998-06-25 AU AU81674/98A patent/AU8167498A/en not_active Abandoned
- 1998-06-25 WO PCT/US1998/013194 patent/WO1999000142A1/en active Application Filing

Also Published As

Publication number	Publication date
WO1999000142A1 (en)	1999-01-07

Publication	Publication Date	Title
AU4878096A (en)	1996-09-18	Hepatitis b vaccine
NO976060D0 (en)	1997-12-23	Vaccines against hepatitis C
AU5504996A (en)	1996-10-23	Composition for inducing a mucosal immune response
AU9052091A (en)	1992-07-22	Vaccines based on hepatitis b surface antigen
AU709406C (en)	2004-04-08	Combined vaccines comprising hepatitis B surface antigen and other antigens
AU4827299A (en)	2000-01-10	Systemic immune activation method using nucleic acid-lipid complexes
AU3210997A (en)	1997-12-09	Dna vaccines for eliciting a mucosal immune response
AU4487293A (en)	1994-03-17	Improved antibodies to plasmodium falciparum
AU634518B2 (en)	1993-02-25	Hepatitis B core antigen conjugates
AU7983198A (en)	1999-01-04	Improved methods for inducing an immune response
IL116100A0 (en)	1996-01-31	Fork lift
AU4450093A (en)	1994-02-10	Hepatitis A virus vaccine
AU5679394A (en)	1994-06-22	Hepatitis b virus vaccines
AU8167498A (en)	1999-01-19	Method for inducing a systemic immune response to a hepatitis or hiv antigen
AU8016998A (en)	1998-12-11	Method for detecting hiv antibodies and antigens used to this end
AU682805B1 (en)	1997-10-16	Method for inducing a systemic immune response to an antigen
GB9704234D0 (en)	1997-04-16	Antibodies to fungal antigens
AU2517895A (en)	1995-12-18	Hiv polyprotein immunogens
AU6295896A (en)	1997-02-05	Assay for hepatitis a virus-specific antibodies
AU7835898A (en)	1999-01-04	A method of enhancing antigen-specific peripheral immune tolerance
GB9514118D0 (en)	1995-09-13	Novel attenvated HIV vaccine
HU0400424D0 (en)	2004-04-28	Hepatitis virus vaccines
GB9725241D0 (en)	1998-01-28	Hiv vaccine
GB9703202D0 (en)	1997-04-02	HIV vaccine
TJ307B (en)	2001-08-06	A method for the preparation of a anti - theileriosis vaccine

Legal Events

Date	Code	Title	Description
2000-03-09	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase